Lantus VS Toujeo Dosing

Lantus is a long-acting insulin that was first approved by the FDA in 2000. It is typically used to treat type 2 diabetes and is taken once daily. Lantus is manufactured by Sanofi-Aventis and its generic name is insulin glargine.

Toujeo is a long-acting insulin that was approved by the FDA in 2015. It is a newer insulin that is very similar to Lantus, another long-acting insulin. Toujeo is a once-daily insulin that is given by injection. It is designed to provide a steady level of insulin throughout the day and night.

Lantus

  1. Lantus is a long-acting insulin that can help control blood sugar levels in people with diabetes.
  2. It is taken once daily, and it can help to keep blood sugar levels under control for up to 24 hours.
  3. It can be used alone or in combination with other diabetes medications.
  4. Lantus has been shown to lower A1C levels, which is a measure of long-term blood sugar control.
  5. It can also help to reduce the risk of complications from diabetes, such as heart disease and stroke.
  6. Lantus is generally well-tolerated, with the most common side effects being mild hypoglycemia and injection site reactions.
  7. It is available in both vials and prefilled pens, so it can be easily administered at home or on the go.
Sheldon Knows Mascot

Toujeo Dosing

  1. Toujeo is a long-acting insulin that can help control blood sugar for up to 36 hours.
  2. Toujeo is designed to provide a steady, consistent level of insulin throughout the day and night.
  3. Toujeo can help reduce the risk of low blood sugar (hypoglycemia) when used alone or in combination with other diabetes medications.
  4. Toujeo may also help improve A1C levels, which is a measure of your average blood sugar over time.

Lantus Vs Toujeo Dosing Comparison

Lantus is the winner because it has a more consistent effect and lasts longer.